These findings are consistent with the previously described luminal phenotype of cancer cells based on strong correlative evidence showing breast cancer cells express luminal markers (such as MUC-1, Keratins 18 and 19 [27]), and lack basal markers (like CD10 and α-SMA [28]). Here, KRT18 is linked to cancer.